bibliographic resource 2249743 [br/2249743]
https://w3id.org/oc/corpus/br/2249743

is a

• document
• article

title

• A Phase II Trial of Salirasib in Patients with Lung Adenocarcinomas with KRAS Mutations

publication date

• 2011-01-01

contributor

• https://w3id.org/oc/corpus/ar/8134482
• https://w3id.org/oc/corpus/ar/8134483
• https://w3id.org/oc/corpus/ar/8134484
• https://w3id.org/oc/corpus/ar/8134485
• https://w3id.org/oc/corpus/ar/8134486
• https://w3id.org/oc/corpus/ar/8134487
• https://w3id.org/oc/corpus/ar/8134488
• https://w3id.org/oc/corpus/ar/8134489
• https://w3id.org/oc/corpus/ar/8134490
• https://w3id.org/oc/corpus/ar/8134491
• https://w3id.org/oc/corpus/ar/8134492
• https://w3id.org/oc/corpus/ar/8134493

format

• https://w3id.org/oc/corpus/re/1174731

identifier

• https://w3id.org/oc/corpus/id/4204104
• https://w3id.org/oc/corpus/id/4204105
• https://w3id.org/oc/corpus/id/4204106

part of

• https://w3id.org/oc/corpus/br/190701